When researchers measure the activity of thousands of genes at once, they face a paradox that has shaped computational biology for decades: far too many variables and far too few samples. A single DNA ...
MGI Tech Co., Ltd. (MGI), a company committed to developing core tools and technologies that drive innovation in life science, launched ...
EpiSign Inc. and Geneyx Genomex Ltd. today announced a partnership to advance the integration of genomic and epigenomic analysis ...
The age at which women have their first child is rising year by year, a trend common to developed countries around the world.
Researchers have discovered that the deubiquitinase USP12 stabilizes the Rab GTPase-activating protein TBC1D22A, activating PI3K-AKT-mTOR signaling and driving ovarian cancer progression, with high ...
EpiSign Inc. and Geneyx Genomex Ltd. announced a partnership to advance the integration of genomic and epigenomic analysis ...
Unlock ROI with segment and regional insights, competitive intelligence, growth opportunities, innovation trends, and actionable strategies for new revenue streams.Dublin, Oct. 05, 2026 (GLOBE ...
GeneDx, the leader in rare disease diagnosis and improving health through the power of genomic data, today announced it will ...
Pacific Biosciences of California's business model struggles to gain traction versus larger, profitable competitors like Illumina. Read why PACB stock is a buy.
One of the biggest health deficits across Africa is the currently unacceptably low levels of immunisation. These are exposing ...
A prespecified analysis of a phase 3 trial evaluated the ability of PAM50 molecular prostate cancer subtypes to predict benefit from salvage treatment intensification.
Reliable classification of lung cancer from chest CT scans is essential for early diagnosis, yet most deep learning (DL) models lack an anatomical basis and robust, quantitatively validated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results